B

Biocept, Inc.

104 employees

Biocept employs cell separation technology to develop a class of diagnostic assays for the early detection and diagnosis of cancer.

Basic info

Industry

biotechnology research

Sectors

non-small cell lung cancer
Biotechnology
cancer diagnostic development
colorectal cancer
gastric cancer
Oncology Testing
molecular testing
melanoma
ctDNA
CTC Testing
Health Diagnostics
diagnostic products
prostate cancer
Health Care
testing services
cancer diagnostics
metastatic breast cancer
clinical services
clinical testing
laboratory testing
liquid biopsy

Date founded

1993

Funding rounds raised

Total raised

$9.3M

from 1 investors over 1 rounds

B

Biocept, Inc. raised $9.3M on March 28, 2017

Investors: ROTH Capital Partners

FAQ